{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T19:57:39Z","timestamp":1792267059026,"version":"4.4.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T00:00:00Z","timestamp":1667174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970443"],"award-info":[{"award-number":["81970443"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970443"],"award-info":[{"award-number":["81970443"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970443"],"award-info":[{"award-number":["81970443"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970443"],"award-info":[{"award-number":["81970443"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970443"],"award-info":[{"award-number":["81970443"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970443"],"award-info":[{"award-number":["81970443"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970443"],"award-info":[{"award-number":["81970443"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970443"],"award-info":[{"award-number":["81970443"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81970443"],"award-info":[{"award-number":["81970443"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Research on the application of clinical characteristics in Beijing","award":["Z171100001017158"],"award-info":[{"award-number":["Z171100001017158"]}]},{"name":"Research on the application of clinical characteristics in Beijing","award":["Z171100001017158"],"award-info":[{"award-number":["Z171100001017158"]}]},{"name":"Research on the application of clinical characteristics in Beijing","award":["Z171100001017158"],"award-info":[{"award-number":["Z171100001017158"]}]},{"name":"Research on the application of clinical characteristics in Beijing","award":["Z171100001017158"],"award-info":[{"award-number":["Z171100001017158"]}]},{"name":"Research on the application of clinical characteristics in Beijing","award":["Z171100001017158"],"award-info":[{"award-number":["Z171100001017158"]}]},{"name":"Research on the application of clinical characteristics in Beijing","award":["Z171100001017158"],"award-info":[{"award-number":["Z171100001017158"]}]},{"name":"Research on the application of clinical characteristics in Beijing","award":["Z171100001017158"],"award-info":[{"award-number":["Z171100001017158"]}]},{"name":"Research on the application of clinical characteristics in Beijing","award":["Z171100001017158"],"award-info":[{"award-number":["Z171100001017158"]}]},{"name":"Research on the application of clinical characteristics in Beijing","award":["Z171100001017158"],"award-info":[{"award-number":["Z171100001017158"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>In-stent neoatherosclerosis (ISNA) is an important reason for stent failure. High lipoprotein (a) [Lp (a)] level is an independent predictor of in-stent restenosis (ISR). To date, the relationship between the level of serum Lp (a) and the incidence rate and vulnerability of ISNA has never been verified.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 119 patients with 125 drug-eluting stent ISR lesions who underwent percutaneous coronary intervention guided by optical coherence tomography were enrolled in this study. According to their Lp (a) level, the patients were divided into two groups [high Lp (a) group\u2009\u2265\u200930\u00a0mg\/dL, n\u2009=\u200947; or low Lp (a) group\u2009&lt;\u200930\u00a0mg\/dL, n\u2009=\u200972]. The clinical baseline, angiographic characteristics, and optical coherence tomography data of both groups were recorded and analyzed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>No significant differences in clinical and angiographic characteristics were found between the two groups (<jats:italic>P<\/jats:italic>\u2009&gt;\u20090.05). The incidence rate of ISNA in the high Lp (a) group was significantly higher than that in the low Lp (a) group (94.0% [n\u2009=\u200947] vs. 52.0% [n\u2009=\u200939], <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001). The incidence rate of thin-cap fibroatheroma in ISR lesions was significantly higher in the high Lp (a) group than in the low Lp (a) group (42% [n\u2009=\u200921] vs. 5.3% [n\u2009=\u20094], <jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>A high Lp (a) level is associated with the high incidence rate and plaque vulnerability of ISNA.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10554-022-02736-3","type":"journal-article","created":{"date-parts":[[2022,10,31]],"date-time":"2022-10-31T06:02:36Z","timestamp":1667196156000},"page":"275-284","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Lipoprotein (a) is related to In-Stent neoatherosclerosis incidence rate and plaque vulnerability: Optical Coherence Tomography Study"],"prefix":"10.1007","volume":"39","author":[{"given":"Xiaohang","family":"Yuan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengting","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanhuan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yundai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,31]]},"reference":[{"issue":"32","key":"2736_CR1","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1093\/eurheartj\/ehv205","volume":"36","author":"F Otsuka","year":"2015","unstructured":"Otsuka F, Byrne RA, Yahagi K et al (2015) Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment. Eur Heart J 36(32):2147\u20132159. https:\/\/doi.org\/10.1093\/eurheartj\/ehv205","journal-title":"Eur Heart J"},{"issue":"10","key":"2736_CR2","doi-asserted-by":"publisher","first-page":"1826","DOI":"10.1253\/circj.CJ-20-0199","volume":"84","author":"Y Sugizaki","year":"2020","unstructured":"Sugizaki Y, Otake H, Kuroda K et al (2020) Concomitant use of rosuvastatin and eicosapentaenoic acid significantly prevents native coronary atherosclerotic progression in patients with in-stent neoatherosclerosis. Circ J 84(10):1826\u20131836. https:\/\/doi.org\/10.1253\/circj.CJ-20-0199","journal-title":"Circ J"},{"issue":"3","key":"2736_CR3","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1590\/1678-4685-GMB-2017-0371","volume":"42","author":"G Cardoso-Salda\u00f1a","year":"2019","unstructured":"Cardoso-Salda\u00f1a G, Fragoso JM, Lale-Farjat S et al (2019) The rs10455872-G allele of the LPA gene is associated with high lipoprotein(a) levels and increased aortic valve calcium in a Mexican adult population. Genet Mol Biol 42(3):519\u2013525. https:\/\/doi.org\/10.1590\/1678-4685-GMB-2017-0371","journal-title":"Genet Mol Biol"},{"issue":"6","key":"2736_CR4","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.jacc.2016.11.042","volume":"69","author":"S Tsimikas","year":"2017","unstructured":"Tsimikas S, Test A (2017) A Test in Context: Lipoprotein(a): Diagnosis, prognosis, controversies, and emerging therapies. J Am Coll Cardiol 69(6):692\u2013711. https:\/\/doi.org\/10.1016\/j.jacc.2016.11.042","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"2736_CR5","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.repc.2019.01.006","volume":"38","author":"JAM Brand\u00e3o","year":"2019","unstructured":"Brand\u00e3o JAM, Meireles-Brand\u00e3o LR, Coelho R et al (2019) Lipoprotein(a) as a key target in combined therapeutic approaches for cardiovascular disease. Rev Port Cardiol 38(7):485\u2013493. https:\/\/doi.org\/10.1016\/j.repc.2019.01.006","journal-title":"Rev Port Cardiol"},{"issue":"1","key":"2736_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s11789-015-0075-z","volume":"10","author":"B Kurt","year":"2015","unstructured":"Kurt B, Soufi M, Sattler A et al (2015) Lipoprotein(a)-clinical aspects and future challenges. Clin Res Cardiol supplements 10(1):26\u201332. https:\/\/doi.org\/10.1007\/s11789-015-0075-z","journal-title":"Clin Res Cardiol supplements"},{"issue":"S1","key":"2736_CR7","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1002\/ccd.26947","volume":"89","author":"J Qi","year":"2017","unstructured":"Qi J, Li Y, Li J et al (2017) Clinical observation of 6-month versus 12-month oral dual-antiplatelet therapy on patients after implantation of biodegradable polymer-coated and drug-eluted long coronary stents-insight from the I-LOVE-IT 2 trial. Catheter Cardiovasc Interv 89(S1):555\u2013564. https:\/\/doi.org\/10.1002\/ccd.26947","journal-title":"Catheter Cardiovasc Interv"},{"key":"2736_CR8","doi-asserted-by":"publisher","first-page":"100382","DOI":"10.1016\/j.ijcha.2019.100382","volume":"24","author":"Y Muramatsu","year":"2019","unstructured":"Muramatsu Y, Minami Y, Kato A et al (2019) Lipoprotein (a) level is associated with plaque vulnerability in patients with coronary artery disease: An optical coherence tomography study. Int J Cardiol 24:100382. https:\/\/doi.org\/10.1016\/j.ijcha.2019.100382","journal-title":"Int J Cardiol"},{"key":"2736_CR9","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.atherosclerosis.2016.01.020","volume":"246","author":"G Niccoli","year":"2016","unstructured":"Niccoli G, Cin D, Scalone G et al (2016) Lipoprotein (a) is related to coronary atherosclerotic burden and a vulnerable plaque phenotype in angiographically obstructive coronary artery disease. Atherosclerosis 246:214\u2013220. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2016.01.020","journal-title":"Atherosclerosis"},{"issue":"18","key":"2736_CR10","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1161\/01.cir.100.18.1872","volume":"100","author":"R Mehran","year":"1999","unstructured":"Mehran R, Dangas G, Abizaid AS et al (1999) Angiographic patterns of in-stent restenosis: Classification and implications for long-term outcome. Circulation 100(18):1872\u20131878. https:\/\/doi.org\/10.1161\/01.cir.100.18.1872","journal-title":"Circulation"},{"issue":"20","key":"2736_CR11","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1093\/eurheartj\/ehs095","volume":"33","author":"F Prati","year":"2012","unstructured":"Prati F, Guagliumi G, Mintz GS et al (2012) Expert review document part 2: Methodology, terminology and clinical applications of optical coherence tomography for the assessment of interventional procedures. Eur Heart J 33(20):2513\u20132520. https:\/\/doi.org\/10.1093\/eurheartj\/ehs095","journal-title":"Eur Heart J"},{"issue":"35","key":"2736_CR12","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1093\/eurheartj\/ehy285","volume":"39","author":"L R\u00e4ber","year":"2018","unstructured":"R\u00e4ber L, Mintz GS, Koskinas KC et al (2018) Clinical use of intracoronary imaging. Part 1: guidance and optimization of coronary interventions. An expert consensus document of the European Association of Percutaneous Cardiovascular Interventions. Eur Heart J 39(35):3281\u20133300. https:\/\/doi.org\/10.1093\/eurheartj\/ehy285","journal-title":"Eur Heart J"},{"issue":"5","key":"2736_CR13","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.rec.2020.03.005","volume":"74","author":"N Gonzalo","year":"2021","unstructured":"Gonzalo N, Salazar CH, P\u00e9rez-Vizcayno MJ et al (2021) Influence of neoatherosclerosis on prognosis and treatment response in patients with in-stent restenosis. Rev Esp Cardiol (Engl Ed) 74(5):427\u2013435. https:\/\/doi.org\/10.1016\/j.rec.2020.03.005","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"issue":"25","key":"2736_CR14","doi-asserted-by":"publisher","first-page":"2954","DOI":"10.1161\/CIRCULATIONAHA.110.988436","volume":"123","author":"SJ Kang","year":"2011","unstructured":"Kang SJ, Mintz GS, Akasaka T et al (2011) Optical coherence tomographic analysis of in-stent neoatherosclerosis after drugeluting stent implantation. Circulation 123(25):2954\u20132963. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.988436","journal-title":"Circulation"},{"issue":"3","key":"2736_CR15","doi-asserted-by":"publisher","first-page":"294","DOI":"10.4244\/EIJ-D-16-00787","volume":"13","author":"L Song","year":"2017","unstructured":"Song L, Mintz GS, Yin D et al (2017) Characteristics of early versus late in-stent restenosis in second-generation drug-eluting stents: An optical coherence tomography study. EuroIntervention 13(3):294\u2013302. https:\/\/doi.org\/10.4244\/EIJ-D-16-00787","journal-title":"EuroIntervention"},{"issue":"3","key":"2736_CR16","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1093\/eurheartj\/ehz520","volume":"41","author":"F Prati","year":"2020","unstructured":"Prati F, Romagnoli E, Gatto L et al (2020) Relationship between coronary plaque morphology of the left anterior descending artery and 12 months clinical outcome: the CLIMA study. Eur Heart J 41(3):383\u2013391. https:\/\/doi.org\/10.1093\/eurheartj\/ehz520","journal-title":"Eur Heart J"},{"key":"2736_CR17","doi-asserted-by":"publisher","unstructured":"Duarte Lau F, Giugliano RP (2022) Lipoprotein(a) and its significance in cardiovascular disease: A review [published online ahead of print, 2022 May 18]. https:\/\/doi.org\/10.1001\/jamacardio.2022.0987. JAMA cardiology Advance online publication","DOI":"10.1001\/jamacardio.2022.0987"},{"issue":"4","key":"2736_CR18","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1161\/01.cir.74.4.758","volume":"74","author":"GH Dahlen","year":"1986","unstructured":"Dahlen GH, Guyton JR, Attar M et al (1986) Association of Levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography. Circulation 74(4):758\u2013765. https:\/\/doi.org\/10.1161\/01.cir.74.4.758","journal-title":"Circulation"},{"issue":"5","key":"2736_CR19","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.amjcard.2016.06.020","volume":"118","author":"BG Kral","year":"2016","unstructured":"Kral BG, Kalyani RR, Yanek LR et al (2016) Relation of plasma lipoprotein(a) to subclinical coronary plaque volumes, Three-Vessel and left main coronary disease, and severe coronary stenoses in apparently healthy African-Americans with a family history of early-onset coronary artery disease. Am J Cardiol 118(5):656\u2013661. https:\/\/doi.org\/10.1016\/j.amjcard.2016.06.020","journal-title":"Am J Cardiol"},{"issue":"3","key":"2736_CR20","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.jacc.2006.03.047","volume":"48","author":"M Hartmann","year":"2006","unstructured":"Hartmann M, von Birgelen C, Mintz GS et al (2006) Relation between lipoprotein(a) and fibrinogen and serial intravascular ultrasound plaque progression in left main coronary arteries. J Am Coll Cardiol 48(3):446\u2013452. https:\/\/doi.org\/10.1016\/j.jacc.2006.03.047","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"2736_CR21","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1001\/jama.2022.5218","volume":"327","author":"L R\u00e4ber","year":"2022","unstructured":"R\u00e4ber L, Ueki Y, Otsuka T et al (2022) Effect of Alirocumab Added to High-Intensity Statin Therapy on Coronary Atherosclerosis in Patients With Acute Myocardial Infarction: The PACMAN-AMI Randomized Clinical Trial. JAMA 327(18):1771\u20131781. https:\/\/doi.org\/10.1001\/jama.2022.5218","journal-title":"JAMA"},{"key":"2736_CR22","doi-asserted-by":"publisher","first-page":"105812","DOI":"10.1016\/j.phrs.2021.105812","volume":"173","author":"M Ruscica","year":"2021","unstructured":"Ruscica M, Sirtori CR, Corsini A et al (2021) Lipoprotein(a): Knowns, unknowns and uncertainties. Pharmacol Res 173:105812. https:\/\/doi.org\/10.1016\/j.phrs.2021.105812","journal-title":"Pharmacol Res"},{"issue":"20","key":"2736_CR23","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1093\/eurheartj\/ehx033","volume":"38","author":"B Gencer","year":"2017","unstructured":"Gencer B, Kronenberg F, Stroes ES et al (2017) Lipoprotein(a): The revenant. Eur Heart J 38(20):1553\u20131560. https:\/\/doi.org\/10.1093\/eurheartj\/ehx033","journal-title":"Eur Heart J"},{"key":"2736_CR24","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.atherosclerosis.2018.04.032","volume":"274","author":"KM Kostner","year":"2018","unstructured":"Kostner KM, Kostner GM, Wierzbicki AS (2018) Is Lp(a) ready for prime time use in the clinic? A pros-and-cons debate. Atherosclerosis 274:16\u201322. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.04.032","journal-title":"Atherosclerosis"},{"issue":"23","key":"2736_CR25","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","volume":"31","author":"BG Nordestgaard","year":"2010","unstructured":"Nordestgaard BG, Chapman MJ, Ray K et al (2010) Lipoprotein(a) as a cardiovascular risk factor: Current status. Eur Heart J 31(23):2844\u20132853. https:\/\/doi.org\/10.1093\/eurheartj\/ehq386","journal-title":"Eur Heart J"},{"issue":"5","key":"2736_CR26","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1038\/s41569-018-0153-2","volume":"16","author":"MB Boffa","year":"2019","unstructured":"Boffa MB, Koschinsky ML (2019) Oxidized phospholipids as a unifying theory for lipoprotein(a) and cardiovascular disease. Nat Rev Cardiol 16(5):305\u2013318. https:\/\/doi.org\/10.1038\/s41569-018-0153-2","journal-title":"Nat Rev Cardiol"},{"issue":"24","key":"2736_CR27","doi-asserted-by":"publisher","first-page":"2511","DOI":"10.1016\/j.jcin.2016.09.016","volume":"9","author":"C Lutter","year":"2016","unstructured":"Lutter C, Mori H, Yahagi K et al (2016) Histopathological differential diagnosis of optical coherence tomographic image interpretation after stenting. JACC Cardiovasc Intv 9(24):2511\u20132523. https:\/\/doi.org\/10.1016\/j.jcin.2016.09.016","journal-title":"JACC Cardiovasc Intv"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-022-02736-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10554-022-02736-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-022-02736-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,24]],"date-time":"2023-01-24T05:32:43Z","timestamp":1674538363000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10554-022-02736-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,31]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,2]]}},"alternative-id":["2736"],"URL":"https:\/\/doi.org\/10.1007\/s10554-022-02736-3","relation":{},"ISSN":["1875-8312"],"issn-type":[{"value":"1875-8312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,31]]},"assertion":[{"value":"23 June 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. The study protocol was approved by the Human Research Committee of the Chinese PLA General Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All patients provided written informed consent before the procedure.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}